No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Shuanglu Pharmaceutical: 2024 Annual Report Summary
Shuanglu Pharmaceutical: 2024 Annual Report
Shuanglu Pharmaceutical: Report for the first quarter of 2025
Express News | Beijing Sl Pharmaceutical: In the first quarter of 2025, the net income was 45.9684 million yuan, a year-on-year decrease of 34.46%.
Express News | Beijing Sl Pharmaceutical: In 2024, the net income loss is 74.0657 million yuan.
Express News | Beijing Sl Pharmaceutical: The company has been approved for a new formulation of nitroglycerin spray.